Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c59e768ffa571bc874ff0e3e29550c01 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
filingDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18dd80af41031bdfd359bcfba7750fd |
publicationDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2020128391-A |
titleOfInvention |
Method of treating depression using NMDA modulators |
abstract |
PROBLEM TO BE SOLVED: To provide a method and regimen for treating depression (eg, treatment-resistant depression) in a patient (eg, a patient in need of such treatment). SOLUTION: The method includes intravenously administering to a patient an effective amount of a composition containing GLYX-13 at regular intervals. [Selection diagram] None |
priorityDate |
2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |